TC
Truvestments Capital Portfolio holdings
AUM
$500M
1-Year Return
21.66%
This Quarter Return
+13.44%
1 Year Return
+21.66%
3 Year Return
+70.79%
5 Year Return
+126.92%
10 Year Return
–
AUM
$500M
AUM Growth
+$39.5M
(+8.6%)
Cap. Flow
-$783K
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
26.84%
Holding
1,111
New
66
Increased
187
Reduced
300
Closed
122
Top Buys
| 1 |
Strategy Inc Common Stock Class A
MSTR
|
+$2.09M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$1.58M |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$695K |
| 4 |
GRNY
FundStrat Granny Shots US Large Cap ETF
GRNY
|
+$369K |
| 5 |
Credo Technology Group
CRDO
|
+$348K |
Top Sells
| 1 |
Wells Fargo
WFC
|
+$2.34M |
| 2 |
Apple
AAPL
|
+$860K |
| 3 |
Invesco S&P 500 Top 50 ETF
XLG
|
+$356K |
| 4 |
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
|
+$299K |
| 5 |
Microsoft
MSFT
|
+$269K |
Sector Composition
| 1 | Technology | 27.84% |
| 2 | Financials | 15.73% |
| 3 | Industrials | 12.04% |
| 4 | Real Estate | 10.42% |
| 5 | Consumer Discretionary | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Littelfuse
LFUS
$6.72B
| $21.4K | ﹤0.01% |
95
-12
| -11% | -$2.71K |
|
527
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.81B
| $21.4K | ﹤0.01% |
436
| – | – |
|
528
Universal Display
OLED
$6.57B
| $21.3K | ﹤0.01% |
138
-27
| -16% | -$4.17K |
|
529
Dimensional US Equity ETF
DFUS
$16.8B
| $21.2K | ﹤0.01% |
317
+1
| +0.3% | +$67 |
|
530
MongoDB
MDB
$27B
| $21.2K | ﹤0.01% |
101
-52
| -34% | -$10.9K |
|
531
Canadian National Railway
CNI
$58.6B
| $20.8K | ﹤0.01% |
200
+100
| +100% | +$10.4K |
|
532
Hilton Worldwide
HLT
$65.4B
| $20.8K | ﹤0.01% |
78
| – | – |
|
533
Medpace
MEDP
$14B
| $20.4K | ﹤0.01% |
65
| – | – |
|
534
Cenovus Energy
CVE
$30.4B
| $20.4K | ﹤0.01% |
1,500
-200
| -12% | -$2.72K |
|
535
Amcor
AMCR
$19.2B
| $20.2K | ﹤0.01% |
2,197
| – | – |
|
536
BridgeBio Pharma
BBIO
$10.1B
| $19.9K | ﹤0.01% |
+460
| New | +$19.9K |
|
537
Andersons Inc
ANDE
$1.4B
| $19.7K | ﹤0.01% |
537
+1
| +0.2% | +$37 |
|
538
iShares S&P 500 Value ETF
IVE
$41.3B
| $19.5K | ﹤0.01% |
100
| – | – |
|
539
Crane NXT
CXT
$3.56B
| $19.5K | ﹤0.01% |
362
+1
| +0.3% | +$54 |
|
540
Chemours
CC
$2.51B
| $19.5K | ﹤0.01% |
1,700
-214
| -11% | -$2.45K |
|
541
Take-Two Interactive
TTWO
$45.5B
| $19.4K | ﹤0.01% |
80
-31
| -28% | -$7.53K |
|
542
iShares Russell 1000 Value ETF
IWD
$64.2B
| $19.4K | ﹤0.01% |
100
-31
| -24% | -$6.02K |
|
543
Viatris
VTRS
$11.9B
| $19.3K | ﹤0.01% |
2,164
-83
| -4% | -$741 |
|
544
Corvus Pharmaceuticals
CRVS
$452M
| $19.1K | ﹤0.01% |
+4,775
| New | +$19.1K |
|
545
Global X US Infrastructure Development ETF
PAVE
$9.51B
| $18.7K | ﹤0.01% |
429
-58
| -12% | -$2.53K |
|
546
Alnylam Pharmaceuticals
ALNY
$61.4B
| $18.7K | ﹤0.01% |
57
| – | – |
|
547
MetLife
MET
$53.4B
| $18.6K | ﹤0.01% |
231
| – | – |
|
548
Collegium Pharmaceutical
COLL
$1.23B
| $18.6K | ﹤0.01% |
629
| – | – |
|
549
Twist Bioscience
TWST
$1.55B
| $18.5K | ﹤0.01% |
+504
| New | +$18.5K |
|
550
MGP Ingredients
MGPI
$603M
| $18K | ﹤0.01% |
602
+2
| +0.3% | +$60 |
|